0001819790-25-000055.txt : 20250320
0001819790-25-000055.hdr.sgml : 20250320
20250320214834
ACCESSION NUMBER: 0001819790-25-000055
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20250318
FILED AS OF DATE: 20250320
DATE AS OF CHANGE: 20250320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Azamian Bobak R.
CENTRAL INDEX KEY: 0001827672
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39614
FILM NUMBER: 25758372
MAIL ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD, SUITE 160
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001819790
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 814717861
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: (949) 409-9820
MAIL ADDRESS:
STREET 1: 15440 LAGUNA CANYON ROAD
CITY: IRVINE
STATE: CA
ZIP: 92618
4
1
wk-form4_1742521708.xml
FORM 4
X0508
4
2025-03-18
0
0001819790
Tarsus Pharmaceuticals, Inc.
TARS
0001827672
Azamian Bobak R.
C/O TARSUS PHARMACEUTICALS, INC.
15440 LAGUNA CANYON ROAD, SUITE 160
IRVINE
CA
92618
1
1
0
0
President/CEO and Board Chair
0
Common Stock
2025-03-18
4
S
0
7131
46.29
D
70720
D
Common Stock
2025-03-19
4
S
0
8551
47.40
D
62169
D
Common Stock
2025-03-20
4
S
0
8534
50.11
D
53635
D
Common Stock
830106
I
By the Bobak Azamian Living Trust established April 16, 2018
The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units. The sale is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares.
/s/ Jeffrey Farrow, Attorney-in-Fact
2025-03-20